Search Results 2701-2710 of 18328 for Chronic Lymphocytic Leukemia
Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able ...
... long term survival. Our goal is to identify ... leukemia/lymphoma. A Study to Evaluate the ... leukaemia (AML)/high-risk myelodysplastic syndrome ...
We aim to recruit 100 subjects (50 survivors and 50 caregivers) to the study. Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including ...
This designation recognizes the institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.
), or other severe endocrinological, gastrointestinal, hepatobiliary, metabolic, pulmonary, or lymphatic diseases. The specific justification for persons ...
Participant has known chronic obstructive pulmonary disease (COPD) (defined as a forced expiratory volume in 1 second [FEV1] <50% of predicted normal), ...
First-in-Human Study of FLX925 in Subjects with Relapsed or Refractory Acute Myeloid Leukemia · Overview · Participation eligibility · Participating Mayo Clinic ...
(ASM), System Mastocytosis (SM) with Associated Hematologic Neoplasm (SM-AHN), and Mast Cell Leukemia (MCL). ... Long-term Survivors of Lung Cancer. Rochester ...
... diagnosis, identify the right treatment, and get it started as quickly as possible. At Mayo Clinic Hematology, we understand that each blood cancer is ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!